Mohs micrographic surgery versus conventional surgical excision in basal cell carcinoma: a comparative review of the literature
DOI:
https://doi.org/10.55892/jrg.v9i20.3512Keywords:
Basal Cell Carcinoma, Mohs Micrographic Surgery, Conventional Surgical Excision, Tumor Recurrence, Margin ControlAbstract
Basal cell carcinoma (BCC) is the most common malignant skin neoplasm and has a high worldwide incidence, representing a significant public health concern. Among the available treatment modalities, conventional surgical excision and Mohs micrographic surgery are widely used in the management of this disease. This study aimed to compare the effectiveness of these two surgical approaches through an integrative literature review. A bibliographic search was conducted in the PubMed/MEDLINE, ScienceDirect, and SciELO databases using descriptors related to basal cell carcinoma and the surgical techniques under investigation. Randomized clinical trials, observational studies, systematic reviews, meta-analyses, and clinical guidelines comparing the two treatment modalities were included. The final sample consisted of nine studies. The results demonstrated that Mohs micrographic surgery provides lower tumor recurrence rates, greater accuracy in surgical margin control, and better tissue preservation when compared with conventional surgical excision, particularly in high-risk, recurrent tumors or lesions located in anatomically critical areas. On the other hand, conventional excision remains an effective alternative for low-risk primary lesions, offering high cure rates and lower operational costs. It is concluded that Mohs micrographic surgery represents the most advantageous approach in clinically complex cases, whereas conventional surgical excision continues to be a safe and effective therapeutic option when appropriately indicated.
Downloads
References
ALSAIF, Abdulmalik et al. Mohs micrographic surgery versus standard excision for basal cell carcinoma in the head and neck: systematic review and meta-analysis. Cureus, Palo Alto, v. 13, n. 11, e19981, 2021. DOI: https://doi.org/10.7759/cureus.19981.
ANDERSEN, Yuki M. F. et al. 10 years of Mohs micrographic surgery in Denmark: results from a nationwide cohort. Acta Dermato-Venereologica, Stockholm, v. 105, p. 1-8, 2025. DOI: https://doi.org/10.2340/actadv.v105.41118.
LACERDA, Priscila Neri et al. Efficacy of micrographic surgery versus conventional excision in reducing recurrence for basal cell carcinoma and squamous cell carcinoma: a systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology, Amsterdam, v. 38, n. 6, p. 1058-1069, 2024. DOI: https://doi.org/10.1111/jdv.19743.
MANSILLA-POLO, M. et al. Review on the role of paraffin-embedded margin-controlled Mohs micrographic surgery to treat skin tumors. Actas Dermo-Sifiliográficas, Madrid, v. 115, n. 6, p. 555-571, 2024. DOI: https://doi.org/10.1016/j.ad.2024.02.017.
MOSTERD, Klara et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. The Lancet Oncology, London, v. 9, n. 12, p. 1149-1156, 2008. DOI: https://doi.org/10.1016/S1470-2045(08)70260-2.
PERIS, Ketty et al. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma: update 2023. European Journal of Cancer, Oxford, v. 192, p. 113254, 2023. DOI: https://doi.org/10.1016/j.ejca.2023.113254.
SMEETS, N. W. J. et al. Surgical excision versus Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. The Lancet, London, v. 364, n. 9447, p. 1766-1772, 2004. DOI: https://doi.org/10.1016/S0140-6736(04)17399-6.
TOLD, Reinhard et al. Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited. Wiener Klinische Wochenschrift, Vienna, v. 137, n. 1-2, p. 7-12, 2025. DOI: https://doi.org/10.1007/s00508-024-02333-5.
VAN LOO, Eva et al. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. European Journal of Cancer, Oxford, v. 50, n. 17, p. 3011-3020, 2014. DOI: https://doi.org/10.1016/j.ejca.2014.08.018.





































